FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes

Article Link: FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes



Source: FDA New Drug Approvals